Amarin Corp Plc (AMRN)
Company News
Amarin and HLS Therapeutics will present scientific data at the Canadian Cardiovascular Congress, highlighting the clinical value of Icosapent Ethyl (IPE) for cardiometabolic conditions and exploring EPA's mechanistic effects on cardiovascular health.
Kymera (KYMR) reports a narrower-than-expected loss in the first quarter. The company expects the current cash balance to provide a runway into the first half of 2027.
AMRN earnings call for the period ending March 31, 2024.
Shares of Butterfly Network, Inc. (NASDAQ: BFLY) fell sharply during Thursday’s session after the company reported mixed fourth-quarter financial results. Butterfly Network posted GAAP loss of 21 cents per share versus market estimates for a loss of 14 cents per share. The company’s quarterly sales came in at sales came in $16.52 million ve...